Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edaravone Dexborneol Concentrated Solution in Acute Ischemic Cerebral Infarction
ChiCTR2100045950Phase 4Recruiting
- Sponsor
- The Second Hospital of Hebei Medical University
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of edaravone dexborneol in brain infarction (2 arms), sponsored by The Second Hospital of Hebei Medical University. Primary endpoints: Blood routine examination, Cytokines and 3 more. Started May 2021; status: recruiting.
02
Drugs
edaravone dexborneol
03
Conditions
brain infarction
Beyond the preview
Go deeper on ChiCTR2100045950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100045950.